Workflow
启迪药业原控股股东所持股份被司法拍卖完成过户登记

Group 1 - The core point of the article is that Tsinghua Unigroup's controlling stake in Qidi Pharmaceutical has been significantly reduced due to a judicial auction, resulting in a new major shareholder [1] - After the transfer of 58.607 million shares, Tsinghua Unigroup's shareholding in Qidi Pharmaceutical decreased from 26.37% to 1.9% [1] - Hunan Sailoxian has become a major shareholder, holding 24.47% of the total shares after previously holding none [1]